Kevin V. Sullivan
Directeur/Bestuurslid bij Qing Bile Therapeutics, Inc.
Actieve functies van Kevin V. Sullivan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Qing Bile Therapeutics, Inc. | Directeur/Bestuurslid | 01-05-2015 | - |
Loopbaan van Kevin V. Sullivan
Eerdere bekende functies van Kevin V. Sullivan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
APPILI THERAPEUTICS INC. | Directeur/Bestuurslid | 01-06-2015 | 02-12-2019 |
Algemeen Directeur | 07-05-2015 | 02-12-2019 | |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology DeNovaMed, Inc. develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs. It focuses in the areas of Gram-positive infections, methicillin-resistant Staph and vancomycin-resistant Enterococcus pose a threat to patients in hospitals and community health facilities by producing skin, wound and systemic infections. The firm also has an ongoing discovery program for Gram-negative adjuvants, which can improve the efficacy of older antibacterial. The company was founded by Donald F. Weaver, Christopher R. McMaster and David Byers in 2006 and is headquartered in Halifax, Canada. | Algemeen Directeur | 01-05-2013 | 01-04-2015 |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Operationeel Directeur | 21-05-2012 | 01-05-2013 |
Corporate Officer/Principal | 01-01-2003 | 21-05-2012 |
Opleiding van Kevin V. Sullivan
Richard Ivey School of Business | Masters Business Admin |
Statistieken
Internationaal
Canada | 5 |
Hongkong | 2 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
APPILI THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology DeNovaMed, Inc. develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs. It focuses in the areas of Gram-positive infections, methicillin-resistant Staph and vancomycin-resistant Enterococcus pose a threat to patients in hospitals and community health facilities by producing skin, wound and systemic infections. The firm also has an ongoing discovery program for Gram-negative adjuvants, which can improve the efficacy of older antibacterial. The company was founded by Donald F. Weaver, Christopher R. McMaster and David Byers in 2006 and is headquartered in Halifax, Canada. | Health Technology |
Qing Bile Therapeutics, Inc. |
- Beurs
- Insiders
- Kevin V. Sullivan
- Ervaring